Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation

Abstract

We report the case of a 54-year-old female patient with stage IIIA kappa light chain myeloma (MM) who relapsed 7 years after syngeneic bone marrow transplantation (BMT). The relapse occurred as a voluminous soft tissue plasmacytoma in the leg, developing after local trauma. The patient was successfully treated with local radiotherapy and has remained progression-free for more than 2 years. This case represents one of the longest survivors, in complete remission, after syngeneic transplantation for MM. The presentation of recurrent disease as localized plasmacytoma with extramedullary growth is unusual in the post-transplant setting. Bone Marrow Transplantation (2000) 25, 115–117.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1
Figure 2

References

  1. Gregory WM, Richards MA, Malpas JS . Combination chemotherapy vs melphalan and prednisone in the treatment of multiple myeloma: an overview of published trials J Clin Oncol 1992 10: 334–342

    Article  CAS  Google Scholar 

  2. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91–97

    Article  CAS  Google Scholar 

  3. Bensinger WI, Buckner CD, Gahrton G . Allogeneic stem cell transplantation for multiple myeloma Hematol/ Oncol Clin N Am 1997 11: 147–157

    Article  CAS  Google Scholar 

  4. Topolsky D, Crilley P, Leasure N et al. Syngeneic marrow transplantation in multiple myeloma Leukemia Res 1992 16: 415–416

    Article  CAS  Google Scholar 

  5. Wolff SN, McCurley TL, Giannone L . High-dose chemo-radiotherapy with syngeneic bone marrow transplantation formultiple myeloma: a case report and literature review Am JHematol 1987 26: 191–198

    Article  CAS  Google Scholar 

  6. Bensinger WI, Demirer T, Buckner CD et al. Syngeneic marrow transplantation in patients with multiple myeloma Bone Marrow Transplant 1996 18: 527–531

    CAS  PubMed  Google Scholar 

  7. Soeson M, Paccagnella A, Chiarion-Sileni V et al. Extramedullary plasmacytoma: clinical behaviour and response to treatment Ann Oncol 1992 3: 51–57

    Article  Google Scholar 

  8. Moreau P, Bataille R, Mahé B et al. High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma J Clin Oncol 1993 11: 1832

    Article  CAS  Google Scholar 

  9. Lokhorst HM, Meuwissen OJ, Verdonck LF et al. High-risk multiple myeloma treated with high-dose melphalan J Clin Oncol 1992 10: 47–51

    Article  CAS  Google Scholar 

  10. Celsing F, Hast R, Stenke L et al. Extramedullary progression of multiple myeloma following GM-CSF treatment Eur J Haematol 1992 49: 108

    Article  CAS  Google Scholar 

  11. Van Riet I, Bakkus M, De Greef C et al. Homing mechanisms in the etiopathogenesis of multiple myeloma Stem Cells 1995 13: (Suppl.2) 22–27

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Trullemans, F., Schots, R., Storme, G. et al. Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation. Bone Marrow Transplant 25, 115–117 (2000). https://doi.org/10.1038/sj.bmt.1702092

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702092

Keywords

  • myeloma
  • extramedullary relapse
  • syngeneic BMT

This article is cited by

Search

Quick links